Since multiple reports have confirmed that activation of Nrf2 may prompt neuroprotective activity in neurodegenerative models, we assume that Akt/Gsk3β-mediated Nrf2 activation could be a target for preventing AD pathology [16–18]. Here, GSK3B is linked to Alzheimer disease.